Innate Pharma (IPHA) Short term Debt (2017 - 2026)
Innate Pharma's Short term Debt was $12.54 million in the quarter ended Jun 30, 2026, up 24.0% from $10.11 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Short term Debt (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Short term Debt at Innate Pharma came in at $9.94 million, up 5.5% from the prior year.
- Short term Debt shows a five-year compound annual growth rate of 32.4% (years ended Dec 2020 to Dec 2025).
- In earlier years, Short term Debt was $9.43 million in the year ended Dec 31, 2024 (-2.5%), $9.67 million in the year ended Dec 31, 2023 (+336.3%), $2.22 million in the year ended Dec 31, 2022 (-93.7%) and $35.17 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Short term Debt since the quarter ended Jun 30, 2022.
- Compared with a year earlier, Short term Debt was higher in three of the last four quarters, with growth averaging 9.0%.
- The best year-over-year quarter for Short term Debt over five years was the quarter ended Dec 31, 2023 (growth of 348.3%); the worst was the quarter ended Dec 31, 2022 (a decline of 93.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.62 Bn | 1,103.20 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.94 Bn | 535.47 Bn | 17.26 Bn |
| 3 | AbbVie | 501.32 Bn | 474.43 Bn | 12.70 Bn |
| 4 | Merck | 367.44 Bn | 321.82 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.20 Bn | 262.19 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.78 Bn | 235.47 Bn | 12.86 Bn |
| 7 | Amgen | 235.70 Bn | 191.10 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.88 Bn | 165.07 Bn | 6.22 Bn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn |
| 10 | Innate Pharma | 141.55 Mn | -65.64 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.91 Mn |
| Dec 31, 2025 | 4.09 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Dec 31, 2024 | 285,128.57 |
| Jun 30, 2024 | 401,567.73 |
| Dec 31, 2023 | 667,411.95 |
| Jun 30, 2023 | 1.91 Mn |
| Dec 31, 2022 | 1.64 Mn |
| Jun 30, 2022 | 816,923.45 |
| Dec 31, 2021 | 732,729.31 |
| Jun 30, 2021 | 6.69 Mn |
| Dec 31, 2020 | 831,473.00 |
| Jun 30, 2020 | 294,676.70 |
| Dec 31, 2019 | 159,072.62 |
| Dec 31, 2018 | 43,471.79 |
| Dec 31, 2017 | 1.21 Mn |
API Access
Innate Pharma Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();